 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- PEG Interferon / Beijing Kawin
Trial completion, Trial primary completion date: Safety Study of Recombinant Interferon Variant(PEG-IFN-SA) to Treat HCV Disease (clinicaltrials.gov) - Jan 27, 2016
P1/2, N=80, Completed, Sponsor: First Hospital of Jilin University
Active, not recruiting --> Completed | Trial primary completion date: May 2012 --> Dec 2013
- ||||||| PEG Interferon / Beijing Kawin
Trial completion, Trial primary completion date: Efficacy and Safety Study of PEG-IFN-SA and Ribavirin to Treat Chronic Hepatitis C (clinicaltrials.gov) - Sep 25, 2015
P3, N=719, Completed, Sponsor: Beijing Kawin Technology Share-Holding Co., Ltd.
Active, not recruiting --> Completed | Trial primary completion date: May 2012 --> Dec 2013 Active, not recruiting --> Completed | Trial primary completion date: Apr 2015 --> Aug 2015
- ||||| PEG Interferon / Beijing Kawin
Enrollment closed: Efficacy and Safety Study of PEG-IFN-SA and Ribavirin to Treat Chronic Hepatitis C (clinicaltrials.gov) - Feb 3, 2015
P3, N=720, Active, not recruiting, Sponsor: Beijing Kawin Technology Share-Holding Co., Ltd.
Active, not recruiting --> Completed | Trial primary completion date: Apr 2015 --> Aug 2015 Not yet recruiting --> Active, not recruiting
- |||| PEG Interferon / Beijing Kawin
Trial completion: A Phase ? Dose-escalating Study of PEG-IFN-SA and Ribavirin in IFN Naive Patients With Chronic Hepatitis C (clinicaltrials.gov) - Oct 20, 2014
P2, N=212, Completed, Sponsor: Beijing Kawin Technology Share-Holding Co., Ltd.
Not yet recruiting --> Active, not recruiting Active, not recruiting --> Completed
- ||||| PEG Interferon / Beijing Kawin
New P2 trial: A Phase ? Dose-escalating Study of PEG-IFN-SA and Ribavirin in IFN Naive Patients With Chronic Hepatitis C (clinicaltrials.gov) - Jul 23, 2013
P2, N=200, Active, not recruiting, Sponsor: Beijing Kawin Technology Share-Holding Co., Ltd.
- ||| PEG Interferon / Beijing Kawin
Enrollment closed: A Phase ? Dose-escalating Study of PEG-IFN-SA and Ribavirin in IFN Naive Patients With Chronic Hepatitis C (clinicaltrials.gov) - Jul 22, 2013
P2, N=200, Active, not recruiting, Sponsor: Beijing Kawin Technology Share-Holding Co., Ltd.
Active, not recruiting --> Completed Not yet recruiting --> Active, not recruiting
- |||||||||| PEG Interferon / Beijing Kawin
New P3 trial: Efficacy and Safety Study of PEG-IFN-SA and Ribavirin to Treat Chronic Hepatitis C (clinicaltrials.gov) - Jul 17, 2013
P3, N=720, Not yet recruiting, Sponsor: Beijing Kawin Technology Share-Holding Co., Ltd.
- | PEG Interferon / Beijing Kawin
New P1/2 trial: Safety Study of Recombinant Interferon Variant(PEG-IFN-SA) to Treat HCV Disease (clinicaltrials.gov) - May 23, 2012
P1/2, N=80, Active, not recruiting, Sponsor: First Hospital of Jilin University